Terms: = Germ cell tumor AND GRIN2A, Q12879, 2903, ENSG00000183454, NMDAR2A, NR2A AND Treatment
5 results:
1. MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line.
Rinner B; Gandolfi G; Meditz K; Frisch MT; Wagner K; Ciarrocchi A; Torricelli F; Koivuniemi R; Niklander J; Liegl-Atzwanger B; Lohberger B; Heitzer E; Ghaffari-Tabrizi-Wizsy N; Zweytick D; Zalaudek I
Sci Rep; 2017 May; 7(1):2098. PubMed ID: 28522871
[TBL] [Abstract] [Full Text] [Related]
2. The genetic basis of new treatment modalities in melanoma.
Kunz M
Curr Drug Targets; 2015; 16(3):233-48. PubMed ID: 25654738
[TBL] [Abstract] [Full Text] [Related]
3. Oncogenes in melanoma: an update.
Kunz M
Eur J Cell Biol; 2014; 93(1-2):1-10. PubMed ID: 24468268
[TBL] [Abstract] [Full Text] [Related]
4. [Melanoma: from molecular studies to the treatment breakthrough].
Imianitov EN
Arkh Patol; 2013; 75(5):63-72. PubMed ID: 24341237
[TBL] [Abstract] [Full Text] [Related]
5. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.
Dalmau J; Tüzün E; Wu HY; Masjuan J; Rossi JE; Voloschin A; Baehring JM; Shimazaki H; Koide R; King D; Mason W; Sansing LH; Dichter MA; Rosenfeld MR; Lynch DR
Ann Neurol; 2007 Jan; 61(1):25-36. PubMed ID: 17262855
[TBL] [Abstract] [Full Text] [Related]
